OptimizeRx Future Growth
Future criteria checks 2/6
OptimizeRx is forecast to grow earnings and revenue by 17.5% and 22.1% per annum respectively while EPS is expected to grow by 29.5% per annum.
Key information
17.5%
Earnings growth rate
29.5%
EPS growth rate
| Healthcare Services earnings growth | 28.7% |
| Revenue growth rate | 22.1% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors
Jan 09
Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)
Aug 24OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely
Aug 16Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?
May 31OptimizeRx: A Top Candidate For My Speculative 'Bio Boom' Portfolio
Oct 12Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?
Sep 23OptimizeRx extends reach with Cooler Screens Partnership
Jul 26OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In Profitability
Jun 27The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business
Nov 16Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All
Aug 13A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)
Jul 15Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation
Jun 24Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist
May 10Estimating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)
Mar 29Don't Ignore The Fact That This Insider Just Sold Some Shares In OptimizeRx Corporation (NASDAQ:OPRX)
Feb 21What Percentage Of OptimizeRx Corporation (NASDAQ:OPRX) Shares Do Insiders Own?
Jan 27
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 113 | -12 | N/A | N/A | 5 |
| 12/31/2024 | 101 | -17 | N/A | N/A | 6 |
| 12/31/2023 | 72 | -18 | -8 | -7 | N/A |
| 9/30/2023 | 63 | -14 | 0 | 2 | N/A |
| 6/30/2023 | 62 | -14 | 2 | 4 | N/A |
| 3/31/2023 | 62 | -14 | 6 | 6 | N/A |
| 12/31/2022 | 62 | -11 | 10 | 11 | N/A |
| 9/30/2022 | 63 | -10 | 6 | 7 | N/A |
| 6/30/2022 | 64 | -7 | 3 | 3 | N/A |
| 3/31/2022 | 64 | -3 | 3 | 3 | N/A |
| 12/31/2021 | 61 | 0 | 0 | 1 | N/A |
| 9/30/2021 | 57 | 1 | -1 | -1 | N/A |
| 6/30/2021 | 52 | 1 | -1 | -1 | N/A |
| 3/31/2021 | 47 | -1 | -1 | -1 | N/A |
| 12/31/2020 | 43 | -2 | -6 | -6 | N/A |
| 9/30/2020 | 34 | -6 | -6 | -5 | N/A |
| 6/30/2020 | 29 | -7 | -7 | -6 | N/A |
| 3/31/2020 | 27 | -5 | -8 | -6 | N/A |
| 12/31/2019 | 25 | -3 | -3 | -2 | N/A |
| 9/30/2019 | 24 | -1 | 0 | 1 | N/A |
| 6/30/2019 | 24 | 1 | 2 | 3 | N/A |
| 3/31/2019 | 22 | 0 | 2 | 2 | N/A |
| 12/31/2018 | 21 | 0 | 1 | 1 | N/A |
| 9/30/2018 | 19 | 0 | 0 | 0 | N/A |
| 6/30/2018 | 16 | -1 | -2 | -2 | N/A |
| 3/31/2018 | 14 | -1 | -2 | -2 | N/A |
| 12/31/2017 | 12 | -2 | -2 | -1 | N/A |
| 9/30/2017 | 10 | -2 | N/A | -2 | N/A |
| 6/30/2017 | 9 | -2 | N/A | -1 | N/A |
| 3/31/2017 | 8 | -2 | N/A | 0 | N/A |
| 12/31/2016 | 8 | -2 | N/A | 0 | N/A |
| 9/30/2016 | 7 | -2 | N/A | 0 | N/A |
| 6/30/2016 | 8 | -1 | N/A | 0 | N/A |
| 3/31/2016 | 7 | -1 | N/A | 0 | N/A |
| 12/31/2015 | 7 | -1 | N/A | 1 | N/A |
| 9/30/2015 | 7 | 0 | N/A | 1 | N/A |
| 6/30/2015 | 7 | 0 | N/A | 0 | N/A |
| 3/31/2015 | 7 | 0 | N/A | 0 | N/A |
| 12/31/2014 | 7 | -1 | N/A | 0 | N/A |
| 9/30/2014 | 6 | -1 | N/A | 1 | N/A |
| 6/30/2014 | 6 | -1 | N/A | 1 | N/A |
| 3/31/2014 | 5 | -1 | N/A | 1 | N/A |
| 12/31/2013 | 5 | 0 | N/A | 1 | N/A |
| 9/30/2013 | 4 | 0 | N/A | 0 | N/A |
| 6/30/2013 | 3 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OPRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OPRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OPRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OPRX's revenue (22.1% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: OPRX's revenue (22.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OPRX's Return on Equity is forecast to be high in 3 years time